Tranylcypromine in mind (Part I): Review of pharmacology

@article{Ulrich2017TranylcypromineIM,
  title={Tranylcypromine in mind (Part I): Review of pharmacology},
  author={S. Ulrich and R. Ricken and M. Adli},
  journal={European Neuropsychopharmacology},
  year={2017},
  volume={27},
  pages={697-713}
}
  • S. Ulrich, R. Ricken, M. Adli
  • Published 2017
  • Psychology, Medicine
  • European Neuropsychopharmacology
  • It has been over 50 years since a review has focused exclusively on the monoamine oxidase (MAO) inhibitor tranylcypromine (TCP). A new review has therefore been conducted for TCP in two parts which are written to be read preferably in close conjunction: Part I - pharmacodynamics, pharmacokinetics, drug interactions, toxicology; and Part II - clinical studies with meta-analysis of controlled studies in depression, practice of TCP treatment, place in therapy. Pharmacological data of this review… CONTINUE READING
    18 Citations
    Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases
    • M. Youdim
    • Chemistry, Medicine
    • Journal of Neural Transmission
    • 2018
    • 29
    MAO inhibitors and their wider applications: a patent review
    • 30
    A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths
    • P. Gillman
    • Psychology, Medicine
    • Journal of Neural Transmission
    • 2018
    • 9
    The effects of tranylcypromine on osteoclastogenesis in vitro and in vivo
    • Zhuochao Liu, K. Yang, +13 authors And Lianfu Deng
    • Chemistry, Medicine
    • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
    • 2019
    • 5
    • Highly Influenced
    Structure‐Based Specific Detection and Inhibition of Monoamine Oxidases and Their Applications in Central Nervous System Diseases
    • Riri Shi, Q. Wu, +8 authors W. Huang
    • Chemistry, Medicine
    • Chembiochem : a European journal of chemical biology
    • 2019
    • 6
    Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs
    • 3
    • PDF
    Parameters for Irreversible Inactivation of Monoamine Oxidase
    • PDF

    References

    SHOWING 1-10 OF 243 REFERENCES
    Tranylcypromine: A review
    • 50
    Tranylcypromine: new perspectives on an "old" drug.
    • 40
    • Highly Influential
    Pharmacokinetics of monoamine oxidase inhibitors.
    • 30
    Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    • 35
    Comparisons of the actions of high and low doses of the MAO inhibitor tranylcypromine on 5-HT2 binding sites in rat cortex.
    • 10
    • Highly Influential
    Lack of pharmacokinetic interaction of carbamazepine with tranylcypromine.
    • 6
    Trimipramine: A challenge to current concepts on antidepressives
    • M. Berger, M. Gastpar
    • Psychology, Medicine
    • European Archives of Psychiatry and Clinical Neuroscience
    • 2005
    • 14
    Comparison of the apparent antidepressant activity of (-) and (+) tranylcypromine in an animal model.
    • 34
    Newer and Older Monoamine Oxidase Inhibitors
    • 46
    • Highly Influential
    Tranylcypromine vs nortriptyline vs placebo in depressed outpatients: a controlled trial
    • 17